Picture of Chrome Holding Co logo

MEHCQ Chrome Holding Co News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Regeneron to buy genetic testing firm 23andMe for $256 million

May 19 (Reuters) - Drugmaker Regeneron Pharmaceuticals REGN.O has agreed to buy genetic testing firm 23andMe Holding MEHCQ.PK  for $256 million, the companies said on Monday.

 (Reporting by Mariam Sunny in Bengaluru; Editing by Leroy Leo)

 ((Mariam.ESunny@thomsonreuters.com))

Recent news on Chrome Holding Co

See all news